チオリダジン
Archives of Ophthalmology 70 (6): 775–778. doi:10.1001/archopht.1963.00960050777009. ISSN 0003-9950. PMID 14065014. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/627402.
↑ “Thioridazine”. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. (2012). https://www.ncbi.nlm.nih.gov/books/n/livertox/Thioridazine/
↑ PubChem Substance Summary: Mesoridazine National Center for Biotechnology Information.
↑ “Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin”.
Clinical Pharmacology & Therapeutics 59 (3): 322–31. (Mar 1996). doi:10.1016/S0009-9236(96)80010-5. PMID 8653995.
↑ PubChem Substance Summary: Sulforidazine National Center for Biotechnology Information.
↑ Daniel WA, Syrek M, Ryłko Z, Kot M (2001). “Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver”. Pol J Pharmacol 53 (6): 615–21. PMID 11985335. http://www.if-pan.krakow.pl/pjp/pdf/2001/6_615.pdf.
↑ “医薬品・医療用具等安全性情報162号”. www.mhlw.go.jp. 厚生労働省. 2021年11月26日閲覧。
↑ “DI月報 No. 220”. 山口大学. 2021年11月26日閲覧。
↑ “Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!”. Int.